As on Thursday, Milestone Pharmaceuticals Inc (NASDAQ: MIST) started slowly as it slid -1.00% to $1.99, before settling in for the price of $2.01 at the close. Taking a more long-term approach, MIST posted a 52-week range of $0.63-$3.06.
It was noted that the giant of the Healthcare sector posted annual sales growth of 28.21% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 28.21%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -6.80%. This publicly-traded company’s shares outstanding now amounts to $85.17 million, simultaneously with a float of $81.09 million. The organization now has a market capitalization sitting at $169.49 million.
Milestone Pharmaceuticals Inc (MIST) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Milestone Pharmaceuticals Inc’s current insider ownership accounts for 4.79%, in contrast to 41.09% institutional ownership. According to the most recent insider trade that took place on Jan 08 ’26, this organization’s President and CEO sold 43,000 shares at the rate of 2.25, making the entire transaction reach 96,750 in total value, affecting insider ownership by 303,721. Preceding that transaction, on Jan 07 ’26, Company’s President and CEO sold 500 for 2.25, making the whole transaction’s value amount to 1,125. This particular insider is now the holder of 346,721 in total.
Milestone Pharmaceuticals Inc (MIST) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.17 per share during the current fiscal year.
Milestone Pharmaceuticals Inc’s EPS decrease for this current 12-month fiscal period is -6.80% and is forecasted to reach -0.51 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -6.42% through the next 5 years, which can be compared against the 28.21% growth it accomplished over the previous five years trading on the market.
Milestone Pharmaceuticals Inc (NASDAQ: MIST) Trading Performance Indicators
Let’s observe the current performance indicators for Milestone Pharmaceuticals Inc (MIST). It’s Quick Ratio in the last reported quarter now stands at 8.24.
In the same vein, MIST’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.86, a figure that is expected to reach -0.16 in the next quarter, and analysts are predicting that it will be -0.51 at the market close of one year from today.
